ALNYLAM PHARMACEUTICALS, INC. Total Liabilities & Equity 2009-2025 | ALNY
What is total liabilities & equity?
Total liabilities and stockholders' equity equals total assets, reflecting the fundamental accounting equation.
What is ALNYLAM PHARMACEUTICALS, INC.'s current total liabilities & equity?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual total liabilities & equity for 2025 was $4.97B, a 17.13% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. total liabilities & equity for the quarter ending December 31, 2025 was $4.97B.
What was ALNYLAM PHARMACEUTICALS, INC.'s total liabilities & equity in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual total liabilities & equity for 2024 was $4.24B, a 10.71% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s total liabilities & equity in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual total liabilities & equity for 2023 was $3.83B, a 7.99% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year total liabilities & equity CAGR?
ALNYLAM PHARMACEUTICALS, INC. total liabilities & equity grew at a compound annual growth rate (CAGR) of 7.83% from FY2020 to FY2025, going from $3.41B to $4.97B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.97B | +17.1% | 10-K |
| FY2024 | $4.24B | +10.7% | 10-K |
| FY2023 | $3.83B | +8.0% | 10-K |
| FY2022 | $3.55B | -2.7% | 10-K |
| FY2021 | $3.64B | +6.9% | 10-K |
| FY2020 | $3.41B | +42.2% | 10-K |
| FY2019 | $2.40B | +52.1% | 10-K |
| FY2018 | $1.57B | -21.1% | 10-K |
| FY2017 | $1.99B | +58.0% | 10-K |
| FY2016 | $1.26B | -8.9% | 10-K |
| FY2015 | $1.39B | +28.4% | 10-K |
| FY2014 | $1.08B | +156.7% | 10-K |
| FY2013 | $420.5M | +46.3% | 10-K |
| FY2012 | $287.5M | +2.0% | 10-K |
| FY2011 | $281.9M | -28.3% | 10-K |
| FY2010 | $393.3M | -18.3% | 10-K |
| FY2009 | $481.4M | - | 10-K |